1. Arnold LE, Aman MG, Cook AM et al. (2006) Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45: 1196–1205
2. Becker K, Wehmeier PM, Schmidt MH (2005) Das noradrenerge Transmittersystem bei ADHS. Thieme, Stuttgart New York
3. Brown TE (2004) Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. J Am Acad Child Adolesc Psychiatry 14: 129–136
4. Buitelaar JK, Danckaerts M, Gillberg Ch et al. (2004) For the Atomoxetine International Study Group: a prospective, multicentre, open-lable assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry 13: 249–257
5. Kratochvil CJ, Wilens TE, Greenhill LL et al. (2006) Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45: 919–927